NCT06289140 - Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions

Biological Availability

Interventions

DIETARY_SUPPLEMENT

Pterostilbene cocrystal (ccPT) - Gelatin capsule

Participants will intake one gelatin capsule with 75 mg of Pterostilbene cocrystal (ccPT).

DIETARY_SUPPLEMENT

Pterostilbene free form (PT)

Participants will intake one capsule with 50 mg of Pterostilbene free form (PT)

DIETARY_SUPPLEMENT

Pterostilbene cocrystal (ccPT) - Gastro-resistant capsule

Participants will intake one gastro-resistant capsule with 75 mg of Pterostilbene cocrystal (ccPT).

Trial Locations (1)

Fundació Eurecat, Reus

All Listed Sponsors

collaborator

Circe, S.L.

UNKNOWN

lead

Fundació Eurecat

OTHER